Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.
Oh G, Wang SC, Pal M, Chen ZF, Khare T, Tochigi M, Ng C, Yang YA, Kwan A, Kaminsky ZA, Mill J, Gunasinghe C, Tackett JL, Gottesman II, Willemsen G, de Geus EJC, Vink JM, Slagboom PE, Wray NR, Heath AC, Montgomery GW, Turecki G, Martin NG, Boomsma DI, McGuffin P, Kustra R, Petronis A. Oh G, et al. Among authors: gunasinghe c. Biol Psychiatry. 2015 Feb 1;77(3):246-255. doi: 10.1016/j.biopsych.2014.06.016. Epub 2014 Jul 1. Biol Psychiatry. 2015. PMID: 25108803 Free PMC article.
Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.
Cohen-Woods S, Gaysina D, Craddock N, Farmer A, Gray J, Gunasinghe C, Hoda F, Jones L, Knight J, Korszun A, Owen MJ, Sterne A, Craig IW, McGuffin P. Cohen-Woods S, et al. Among authors: gunasinghe c. Hum Mol Genet. 2009 Apr 15;18(8):1504-9. doi: 10.1093/hmg/ddp051. Epub 2009 Jan 30. Hum Mol Genet. 2009. PMID: 19181679
A follow-up case-control association study of tractable (druggable) genes in recurrent major depression.
Schosser A, Gaysina D, Cohen-Woods S, Domenici E, Perry J, Tozzi F, Korszun A, Gunasinghe C, Gray J, Jones L, Binder EB, Holsboer F, Craddock N, Owen MJ, Craig IW, Farmer AE, Muglia P, McGuffin P. Schosser A, et al. Among authors: gunasinghe c. Am J Med Genet B Neuropsychiatr Genet. 2011 Sep;156B(6):640-50. doi: 10.1002/ajmg.b.31204. Epub 2011 May 31. Am J Med Genet B Neuropsychiatr Genet. 2011. PMID: 21630437
Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.
Schosser A, Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Craddock N, Farmer A, Korszun A, Gunasinghe C, Gray J, Jones L, Tozzi F, Perry J, Muglia P, Owen MJ, Craig IW, McGuffin P. Schosser A, et al. Among authors: gunasinghe c. Mol Psychiatry. 2010 Aug;15(8):844-9. doi: 10.1038/mp.2009.21. Epub 2009 Mar 3. Mol Psychiatry. 2010. PMID: 19255581
The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder.
Cohen-Woods S, Craig I, Gaysina D, Gray J, Gunasinghe C, Craddock N, Elkin A, Jones L, Kennedy J, King N, Korszun A, Knight J, Owen M, Parikh S, Strauss J, Sterne A, Tozzi F, Perry J, Muglia P, Vincent J, McGuffin P, Farmer A. Cohen-Woods S, et al. Among authors: gunasinghe c. Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1298-304. doi: 10.1002/ajmg.b.31101. Am J Med Genet B Neuropsychiatr Genet. 2010. PMID: 20552676
CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP.
Huezo-Diaz P, Perroud N, Spencer EP, Smith R, Sim S, Virding S, Uher R, Gunasinghe C, Gray J, Campbell D, Hauser J, Maier W, Marusic A, Rietschel M, Perez J, Giovannini C, Mors O, Mendlewicz J, McGuffin P, Farmer AE, Ingelman-Sundberg M, Craig IW, Aitchison KJ. Huezo-Diaz P, et al. Among authors: gunasinghe c. J Psychopharmacol. 2012 Mar;26(3):398-407. doi: 10.1177/0269881111414451. Epub 2011 Sep 17. J Psychopharmacol. 2012. PMID: 21926427 Clinical Trial.
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.
Hannon E, Dempster EL, Mansell G, Burrage J, Bass N, Bohlken MM, Corvin A, Curtis CJ, Dempster D, Di Forti M, Dinan TG, Donohoe G, Gaughran F, Gill M, Gillespie A, Gunasinghe C, Hulshoff HE, Hultman CM, Johansson V, Kahn RS, Kaprio J, Kenis G, Kowalec K, MacCabe J, McDonald C, McQuillin A, Morris DW, Murphy KC, Mustard CJ, Nenadic I, O'Donovan MC, Quattrone D, Richards AL, Rutten BP, St Clair D, Therman S, Toulopoulou T, Van Os J, Waddington JL; Wellcome Trust Case Control Consortium (WTCCC); CRESTAR consortium; Sullivan P, Vassos E, Breen G, Collier DA, Murray RM, Schalkwyk LS, Mill J. Hannon E, et al. Among authors: gunasinghe c. Elife. 2021 Feb 26;10:e58430. doi: 10.7554/eLife.58430. Elife. 2021. PMID: 33646943 Free PMC article.
26 results